產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
---|---|---|---|---|---|---|---|
201122-500MG |
|
1884457-36-6 |
(2R,3R)-4-(2,6-二甲氧基苯基)-3-叔丁基-2,3-二氫-2-(苯甲基)-1,3-苯并氧膦雜環(huán) (2R,3R)-4-(2,6-Dimethoxyphenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-2-(phenylmethyl)-1,3-benzoxaphosphole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
500MG | 需詢價(jià) | C26H29O3P | |
201122-100MG |
|
1884457-36-6 |
(2R,3R)-4-(2,6-二甲氧基苯基)-3-叔丁基-2,3-二氫-2-(苯甲基)-1,3-苯并氧膦雜環(huán) (2R,3R)-4-(2,6-Dimethoxyphenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-2-(phenylmethyl)-1,3-benzoxaphosphole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C26H29O3P | |
201121-500MG |
|
1373432-13-3 |
(2S,3S)-4-(2,6-二甲氧基苯基)-3-叔丁基-2,3-二氫-2-(苯甲基)-1,3-苯并氧膦雜環(huán) (2S,3S)-4-(2,6-Dimethoxyphenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-2-(phenylmethyl)-1,3-benzoxaphosphole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
500MG | 需詢價(jià) | C26H29O3P | |
201121-100MG |
|
1373432-13-3 |
(2S,3S)-4-(2,6-二甲氧基苯基)-3-叔丁基-2,3-二氫-2-(苯甲基)-1,3-苯并氧膦雜環(huán) (2S,3S)-4-(2,6-Dimethoxyphenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-2-(phenylmethyl)-1,3-benzoxaphosphole 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C26H29O3P | |
201152-1G |
|
NA |
(4S)-3,3'-雙(3,5-(3,5-二(三氟甲基苯基))苯基)-1,1'-聯(lián)萘酚磷酸酯 (4S)-4-Hydroxy-2,6-bis(3,3'',5,5''-tetrakis(trifluoromethyl)-[1,1':3',1''-terphenyl]-5'-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-oxide 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
1G | 需詢價(jià) | C64H29F24O4P | |
201152-100MG |
|
NA |
(4S)-3,3'-雙(3,5-(3,5-二(三氟甲基苯基))苯基)-1,1'-聯(lián)萘酚磷酸酯 (4S)-4-Hydroxy-2,6-bis(3,3'',5,5''-tetrakis(trifluoromethyl)-[1,1':3',1''-terphenyl]-5'-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-oxide 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C64H29F24O4P | |
201152-25MG |
|
NA |
(4S)-3,3'-雙(3,5-(3,5-二(三氟甲基苯基))苯基)-1,1'-聯(lián)萘酚磷酸酯 (4S)-4-Hydroxy-2,6-bis(3,3'',5,5''-tetrakis(trifluoromethyl)-[1,1':3',1''-terphenyl]-5'-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-oxide 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
25MG | 需詢價(jià) | C64H29F24O4P | |
201151-1G |
|
NA |
(4R)-3,3'-雙(3,5-(3,5-二(三氟甲基苯基))苯基)-1,1'-聯(lián)萘酚磷酸酯 (4R)-4-Hydroxy-2,6-bis(3,3'',5,5''-tetrakis(trifluoromethyl)-[1,1':3',1''-terphenyl]-5'-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-oxide 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
1G | 需詢價(jià) | C64H29F24O4P | |
201151-100MG |
|
NA |
(4R)-3,3'-雙(3,5-(3,5-二(三氟甲基苯基))苯基)-1,1'-聯(lián)萘酚磷酸酯 (4R)-4-Hydroxy-2,6-bis(3,3'',5,5''-tetrakis(trifluoromethyl)-[1,1':3',1''-terphenyl]-5'-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-oxide 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C64H29F24O4P | |
201151-25MG |
|
NA |
(4R)-3,3'-雙(3,5-(3,5-二(三氟甲基苯基))苯基)-1,1'-聯(lián)萘酚磷酸酯 (4R)-4-Hydroxy-2,6-bis(3,3'',5,5''-tetrakis(trifluoromethyl)-[1,1':3',1''-terphenyl]-5'-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-oxide 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
25MG | 需詢價(jià) | C64H29F24O4P | |
201069-500MG |
|
74839-84-2 |
1,1'-[(1R,2R)-1,2-二甲基-1,2-乙二亞甲基]雙(1,1-二苯基膦) 1,1'-[(1R,2R)-1,2-Dimethyl-1,2-ethanediyl]bis[1,1-diphenyl-phosphine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
500MG | 需詢價(jià) | C28H28P2 | |
201069-100MG |
|
74839-84-2 |
1,1'-[(1R,2R)-1,2-二甲基-1,2-乙二亞甲基]雙(1,1-二苯基膦) 1,1'-[(1R,2R)-1,2-Dimethyl-1,2-ethanediyl]bis[1,1-diphenyl-phosphine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C28H28P2 | |
201068-500MG |
|
64896-28-2 |
1,1'-[(1S,2S)-1,2-二甲基-1,2-乙二亞甲基]雙(1,1-二苯基膦) 1,1'-[(1S,2S)-1,2-Dimethyl-1,2-ethanediyl]bis[1,1-diphenyl-phosphine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
500MG | 需詢價(jià) | C28H28P2 | |
201068-100MG |
|
64896-28-2 |
1,1'-[(1S,2S)-1,2-二甲基-1,2-乙二亞甲基]雙(1,1-二苯基膦) 1,1'-[(1S,2S)-1,2-Dimethyl-1,2-ethanediyl]bis[1,1-diphenyl-phosphine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C28H28P2 | |
201067-100MG |
|
133545-25-2 |
1,1'-[(1S)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙[1,1-雙(4-苯甲基)膦 1,1'-[(1S)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-bis(4-methylphenyl)-phosphine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C42H40O2P2 | |
201066-100MG |
|
133545-24-1 |
1,1'-[(1R)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙[1,1-雙(4-苯甲基)膦 1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-bis(4-methylphenyl)-phosphine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C42H40O2P2 | |
201065-100MG |
|
133545-17-2 |
1,1'-[(1S)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙(1,1-二苯基膦) 1,1'-[(1S)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis(1,1-diphenyl)-phosphine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C38H32O2P2 | |
201064-100MG |
|
133545-16-1 |
1,1'-[(1R)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙(1,1-二苯基膦) 1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis(1,1-diphenyl)-phosphine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C38H32O2P2 | |
201387-1G |
|
2262535-73-7 |
[S(R)]-N-[(S)-[3,5-雙(三氟甲基)苯基][2-(二苯基膦)苯基]甲基]-2-甲基-2-叔丁基亞磺酰胺 [S(R)]-N-[(S)-[3,5-Bis(trifluoromethyl)phenyl][2- (diphenylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C31H28F6NOPS | |
201387-100MG |
|
2262535-73-7 |
[S(R)]-N-[(S)-[3,5-雙(三氟甲基)苯基][2-(二苯基膦)苯基]甲基]-2-甲基-2-叔丁基亞磺酰胺 [S(R)]-N-[(S)-[3,5-Bis(trifluoromethyl)phenyl][2- (diphenylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C31H28F6NOPS | |